Neurological disorders, such as epilepsy, Parkinson’s disease, and multiple sclerosis, can have a significant impact on an individual’s quality of life. CBD has been found to have neuroprotective properties, which may make it a promising treatment option for individuals with these conditions.
Research has shown that CBD can interact with the body’s endocannabinoid system and other signaling pathways in the brain, which may help protect neurons from damage and degeneration. In a 2018 review published in the journal Molecules, researchers found that CBD has potential as a neuroprotective agent and may be beneficial for a range of neurological disorders.
One of the most well-known examples of CBD’s neuroprotective properties is its use in treating epilepsy. In fact, the first CBD-based drug, Epidiolex, was approved by the FDA in 2018 for the treatment of two rare forms of childhood epilepsy. CBD has been found to help reduce the frequency and severity of seizures in individuals with epilepsy.
CBD may also be beneficial for individuals with Parkinson’s disease. In a 2014 study published in the Journal of Psychopharmacology, researchers found that CBD can help improve motor function and reduce symptoms of Parkinson’s disease in animal models.
Additionally, CBD may be beneficial for individuals with multiple sclerosis. In a 2019 study published in the Journal of Neurology, researchers found that CBD can help reduce spasticity and improve quality of life in individuals with multiple sclerosis.
It’s important to note that while CBD has shown potential as a neuroprotective agent, more research is needed to fully understand its mechanisms of action and long-term effects. As with any supplement or medication, it’s important to speak with a healthcare provider before starting to use CBD for neuroprotective purposes.